Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

SEC Made Actions Against West End And Touradji

SEC recently made legal actions against West End Financial Advisors and Touradji Capital Management, according to a HFN report.

Kevin Kramer, 60 years old, is the former president and chief operating officer in West End Financial Advisors. He was accused by SEC for knowing, “or was reckless in not knowing that West End faced severe financial problems and that the West End funds were not performing as represented to investors.”

Previously Kramer was involved in a lawsuit in January that charged him with fraud with its former CEO William Landberg, who was charged Landberg with misusing client funds to cover his failed investment strategies.

West End is a New Yorkbased, unregistered hedge fund adviser to a collection of hedge funds.

Meanwhile, SEC charged Touradji Capital Management $1.3 million in penalty for its violations during October 2007 through July 2008. “Touradji Capital bought offered shares from an underwriter or broker or dealer participating in a follow-on public offering after having sold short the same security during the restricted period. These violations collectively resulted in profits of approximately $834,000.” according to the SEC release.

Touradji Capital is under Delaware law and is located in New York, New York. During the period, Touradji Capital managed three hedge funds: Touradji Global Resources Master Fund Ltd., Touradji Deeprock Master Fund Ltd. and Touradji Diversified Master Fund Ltd.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!